None listed
Conditions
Brief summary
A randomized controlled study of MiDoctor, an automated system that uses text messaging (SMS) to reinforce patient attendance, helps patients adhere to medication and lifestyle changes, and alerts health personnel to inadequate adherence or changes in risk factors. The study population consists of 1,054 patients with diabetes type 2, at least 18 years old, registered at Hospital de Curacavi, Chile, of whom 650 will be invited to participate in MiDoctor, while 404 controls will receive their usual care. One-year endpoints will include hemoglobin A1c, blood pressure, LDL cholesterol, urinary microalbumin, and patient adherence to appointments and medications. Intention to treat (ITT) analysis is planned, along with a supplementary per-protocol (PP) analysis of based upon acceptance of the invitation to participate.
Interventions
Patients in the intervention group will be invited to participate for 12 months in "MiDoctor," an automated system that monitors individuals with chronic diseases and promotes self-care by providing timely diagnosis, automated calls, and continual reminders via text messaging. The system reinforces patient attendance, helps patients adhere to medication and lifestyle changes, and alerts health personnel to inadequate adherence or changes in risk factors. Specifically, MiDoctor is a web-based sys
Patients in the intervention group will be invited to participate for 12 months in "MiDoctor," an automated system that monitors individuals with chronic diseases and promotes self-care by providing timely diagnosis, automated calls, and continual reminders via text messaging. The system reinforces patient attendance, helps patients adhere to medication and lifestyle changes, and alerts health personnel to inadequate adherence or changes in risk factors. Specifically, MiDoctor is a web-based system with an interactive voice response (IVR) component and SMS components. The system makes automated phone calls and sends SMS to the patient and, depending on the patient's response, it will send an email alert and place the patient on a work list for the clinical team to respond. The system calls the patient approximately once a week and sends them 1 SMS per week. Each automated phone call lasts approximately 1.5 minutes.
Sponsors
Jeffrey E. Harris
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Patients with an established diagnosis of diabetes mellitus type 2, with or without hypertension, registered at Curacavi Hospital, Chile, as of June 15, 2014.
Exclusion criteria
None
Outcome results
None listed